Trial reportQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2026
A pilot study of body-mind-spirit group therapy on sleep and quality of life in individuals with visual impairment.
Trial report in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07105761 (Effects of Body-mind-spirit Group Therapy on Holistic Well-being and Depression in Individuals With Visual Impairment), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effects of Body-mind-spirit Group Therapy on Holistic Well-being and Depression in Individuals With Visual Impairment
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study evaluated the feasibility and preliminary effects of body–mind–spirit (BMS) group therapy—integrating Eastern gratitude philosophies with Western psychotherapy—on sleep and quality of life (QoL) among adults with visual impairment (VI).
methodsA quasi-experimental study recruited 30 adults with VI (mean age 61.5 ± 11.4 years, range 26–78; 53.3% female). The experimental group received 10 weekly 130-min BMS sessions; the control group received usual care. QoL was assessed using the WHOQOL-BREF, and sleep was measured through accelerometry (XA-5) and self-reports.
resultsCompared with the comparison group, the intervention group showed significant improvements in overall QoL (p = 0.01, d = 0.58), with the most robust effect observed in physical health (d = 0.71). While objective sleep metrics remained statistically unchanged, the experimental group reported moderate improvements in sleep latency (d = −0.32; 23% reduction) and increased satisfaction. Data stability was influenced by a perceived lack of security in wearable devices. Notably, longer sleep duration correlated with better psychological well-being (p = 0.01), while lower gains among younger participants were linked to significantly shorter baseline sleep duration associated with their occupations.
conclusionBMS therapy is feasible and may enhance QoL and subjective sleep through improved emotional regulation. Although “circadian hardwiring” may limit physiological reset, BMS offers a psychological buffer against sleep dissatisfaction. Future trials should integrate circadian-focused strategies and address cultural conservatism regarding sensitive QoL dimensions.
trial registrationIRB of Taipei City Hospital (TCHIRB-11107010); ClinicalTrials.gov (NCT07105761); Registration date: 13 August 2025.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.